This inventor holds 1 USPTO granted patent. Top assignee: Kangwon National University Industry Cooperation Foundation. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Byeong Su Kim
Introduction
Byeong Su Kim is a notable inventor based in Chuncheon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of ezetimibe, a medication used to lower cholesterol levels. His innovative methods have the potential to enhance the efficiency of drug production.
Latest Patents
Byeong Su Kim holds 1 patent for a method of preparing ezetimibe and its intermediate. This patent discloses a technique that includes cross-metathesis using a Grubbs catalyst and deprotection using a Pearlman's catalyst. The method is particularly useful in pharmaceutical applications, providing an efficient synthesis technique for ezetimibe.
Career Highlights
Kim is affiliated with the Kangwon National University Industry Cooperation Foundation, where he applies his expertise in pharmaceutical research. His work focuses on developing innovative methods that can streamline drug synthesis processes, contributing to advancements in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Phil Ho Lee and Koo Yeon Lee, to further enhance research and development in his field. Their combined efforts aim to push the boundaries of pharmaceutical innovation.
Conclusion
Byeong Su Kim's contributions to the field of pharmaceuticals through his innovative patent on ezetimibe synthesis exemplify the impact of dedicated inventors in advancing medical science. His work continues to inspire future innovations in drug development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile